Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin-II antagonist and/or a diuretic

Details for Australian Patent Application No. 2009319362 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Kuhl, Alexander; Brendel, Erich; Brocker, Frank; Funke, Adrian; Ohm, Andreas; Kvesic, Dennis; Volkmer, Thomas

Agent Davies Collison Cave

Pub. Number AU-A-2009319362

PCT Pub. Number WO2010/060564

Priority 10 2008 059 206.4 27.11.08 DE

Filing date 19 November 2009

Wipo publication date 3 June 2010

International Classifications

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 31/4178 (2006.01)

A61K 31/4184 (2006.01)

A61K 31/4422 (2006.01) - 1,4-Dihydropyridines, e.g. nifedipine, nicardipine

Event Publications

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/060564 Priority application(s): WO2010/060564

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009319367-Improved optical brightening compositions for high quality ink jet printing

2009319350-Method for producing semiconductor layers and coated substrates treated with elemental selenium and/or sulfur, in particular flat substrates